| Dr Glen Heise, MD | |
|
2 S 21st St, Harrisburg, PA 17104-1314 | |
| (717) 238-1513 | |
| Not Available |
| Full Name | Dr Glen Heise |
|---|---|
| Gender | Male |
| Speciality | Family Medicine |
| Location | 2 S 21st St, Harrisburg, Pennsylvania |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1972596955 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | MD029515E (Pennsylvania) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Glen Heise, MD 2 S 21st St, Harrisburg, PA 17104-1314 Ph: (717) 238-1513 | Dr Glen Heise, MD 2 S 21st St, Harrisburg, PA 17104-1314 Ph: (717) 238-1513 |
News Archive
Physicians at the University of Rochester Medical Center have identified a method that appears to reliably predict the birth weight of babies in obese pregnant women, a key factor in counseling patients and planning for safe delivery of their babies.
Shire plc, the global specialty biopharmaceutical company, announced new data about the pharmacokinetics of its Attention-Deficit/Hyperactivity Disorder (ADHD) medication, Vyvanse- (lisdexamfetamine dimesylate) Capsules CII, which showed that Vyvanse provided similar concentrations of its active medication in the blood when administered either intranasally or when administered orally.
Months after recovering from mild cases of COVID-19, people still have immune cells in their body pumping out antibodies against the virus that causes COVID-19, according to a study from researchers at Washington University School of Medicine in St. Louis. Such cells could persist for a lifetime, churning out antibodies all the while.
Sermo, the world's largest online community for physicians, today announced a Sermo Event Report titled "Is there any Threat to Anti-TNFs from Newer Biologic DMARDs?" In the past year, the FDA has approved four new biologic DMARDs – Actemra (Genentech), Orencia (Bristol-Myers Squibb), Simponi (Centocor Ortho Biotech), and Cimzia (UCB). According to the report, Orencia leads the pack among physicians as the next line of treatment for patients who fail two or more TNF antagonists.
› Verified 8 days ago
David Metzger, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 111 S Front St, Harrisburg, PA 17101 Phone: 717-231-8772 Fax: 717-231-8435 | |
Dr. Michael Timothy Partin, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 121 Nyes Road, Suite A, Hp09, Harrisburg, PA 17112 Phone: 717-657-4040 Fax: 717-671-9038 | |
Jarrett Keller Sell, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2626 N 3rd St, Harrisburg, PA 17110 Phone: 717-232-5443 Fax: 717-232-4553 | |
Melissa Denham Gage, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 5125 Jonestown Rd Ste 105, Harrisburg, PA 17112 Phone: 717-943-1566 | |
Abraham Robert Taylor, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 121 N Nyes Rd Ste A, Harrisburg, PA 17112 Phone: 717-657-4040 Fax: 717-671-9038 | |
Dr. Denise F Montisano, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 805 Sir Thomas Ct, 2nd Floor, Harrisburg, PA 17109 Phone: 717-657-3030 Fax: 717-671-0991 | |
Dr. Bolanle Asuni Limann, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 110 S 17th St, Harrisburg, PA 17104 Phone: 717-232-9971 |